Source map — Amgen drug combined with immunotherapy extends survival in lung cancer trial
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| CNBC | news | 60% |
| Amgen | news | 60% |
| NBC News | news | 60% |
| Fierce Pharma | news | 60% |
| Reuters | news | 60% |
| Bloomberg.com | news | 60% |
| Bioengineer.org | news | 60% |
| www.cnbc.com | news | 50% |
| www.marketscreener.com | news | 50% |
| arynews.tv | news | 50% |
| www.yahoo.com | news | 50% |
| ca.marketscreener.com | news | 50% |
| www.amgen.com | news | 50% |
| pharma.economictimes.indiatimes.com | news | 50% |
| www.healthandme.com | news | 50% |